Ondansetron for pediatric concussion; a pilot study for a randomized controlled trial - Gravel J, Carri ère B, D'Angelo A, Crevier L, Beauchamp MH, Masse B.

OBJECTIVES: Assess the feasibility of a study evaluating one dose of oral ondansetron to decrease post-concussion symptoms at one week and one month following concussion in children aged 8 to 17 years old. METHOD: This was a pilot study for a rando...
Source: SafetyLit - Category: Global & Universal Tags: Age: Adolescents Source Type: news